Greenville, SCNCT07629726Now EnrollingIRB Ready

Hematologic Neoplasms Clinical Trial in Greenville, SC

Access cutting-edge hematologic neoplasms treatment through this clinical trial at a research site in Greenville. Study-provided care at no cost to qualified participants.

Sponsored by Kyowa Kirin Co., Ltd.

Quick Self-Assessment

See if you qualify for this Greenville location

Preparing your pre-screening questions…

Expert Care in Greenville

Access hematologic neoplasms specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hematologic neoplasms treatment provided free

Apply for This Greenville Location

Check if you qualify for this hematologic neoplasms clinical trial in Greenville, SC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Greenville

    Convenient for SC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Greenville site if eligible
  4. 4Begin participation

About This Hematologic Neoplasms Study in Greenville

KK2430 ("Study Drug") as a potential treatment for people with Hematologic Neoplasms. KK2430 is an experimental drug; it has not been approved for the treatment of any disease by health authorities such as United States Food and Drug Administration (FDA), and this is the first time it will be given to people. The purpose of this Study is to find out more information about KK2430, whether it is safe in humans, how the body processes it, and if it works for treating your condition.

Sponsor: Kyowa Kirin Co., Ltd.

Who Can Participate

Inclusion Criteria

Participants must be at least 18 years of age at the time of signing the informed consent.
At least 1 measurable diseases based on CT scan or MRI
Renal function values
Participants who have an ECOG PS score of 0, 1 or 2.
Be willing to provide a fresh tissue taken at current relapse at screening period.
Meet laboratory values at Screening i.e., ANC, Platelets, Corrected serum calcium, AST and ALT, Total bilirubin etc
Contraceptive use by \[men and women\] should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies.
Women of childbearing potential and fertile men must agree to use highly effective contraceptive methods • At least 1 measurable diseases based on CT scan or MRI
Capable of giving signed informed consent
Health Information Access: Capable of providing access to personal health information via HIPAA authorization (US only).
Legal Status: Not under any administrative or legal supervision or institutionalization due to regulatory or juridical order.

Exclusion Criteria

Medical Conditions
History of prior allogenic transplant.
Presence of Grade 2 peripheral neuropathy with pain.
Impaired cardiac function or clinically significant cardiac disease at Screening
Known active CNS involvement or clinical signs of meningeal involvement.
Evidence of HIV infection.
Active chronic HBV/HCV infection,
Participants with positive anti-HBc must have a negative HBV-DNA quantification test result to be enrolled.
Receipt of any anti-tumor therapy within three weeks or at least five half-lives prior to the Screening visit, whichever is shorter.
Toxicities from prior anticancer therapies that have not resolved to Grade 1 or less except for abnormal clinical values alopecia and peripheral neuropathy (participants with Grade 1 or 2 neuropathy without pain are eligible for enrollment).
Use of systemic corticosteroids exceeding 10 mg/day of prednisone or equivalent within 14 days prior to the first dose

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Greenville?

Yes, this clinical trial (NCT07629726) has an active research site in Greenville, SC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hematologic Neoplasms Treatment Options in Greenville, SC

If you're searching for hematologic neoplasms treatment options in Greenville, SC, this clinical trial (NCT07629726) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Greenville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hematologic neoplasms specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hematologic neoplasms clinical trials near you to find additional studies recruiting in your area.

More Multiple Sclerosis Trials in Greenville, SC

See all multiple sclerosis clinical trials recruiting in Greenville — not just this study.

Browse Multiple Sclerosis Trials in Greenville →

Browse More Trials by Condition

Multiple Sclerosis TrialsAnkylosing Spondylitis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Greenville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Greenville, SC